In 2022, Wang et al. investigated the relationship between serum levels of irisin and BMD in patients with new-onset type 2 diabetes and observed that decreased serum levels of irisin were negatively associated with BMD. This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.